4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015019
Options or other derivatives
- COO acquired 0 shares (grant or award)
- COO acquired 0 shares (option exercise)
- COO acquired 38,473 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Horowitz Bruce COO | 2021-06-17 | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | D | |||
| Horowitz Bruce COO | 2021-06-20 | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | D | ||
| Horowitz Bruce COO | 2021-06-20 | Option exercise · Series D-1 Convertible Preferred Stock | +38,473 | 38,473 | D | ||
Loading xslF345X03/ownership.xml…